9 completed, 2 recruiting, 1 active not recruiting, 1 suspended. 15 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 15 | Completed 9, Recruiting 2, Active not recruiting 1, Suspended 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 3, Recruiting 1, Suspended 1, Unknown 1 |
Follow Fluid Therapy: new trials by email Literature Review of Fluid Therapy trials Research Report on Fluid Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of Topical Exosome-Containing Liquid in Healthy Volunteers Exosome-Containing Liquid, Vehicle Liquid - Skin Irritation, Healthy Volunteers | Phase 1 | Active not recruiting | West Kazakhstan Marat Ospanov Medical University | 10 | 2026-09-25 | 2026-10-09 |
| A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity AMG 133 (frozen liquid), AMG 133 (liquid) - Overweight and Obesity | Phase 1 | Completed | Amgen | 154 | 2024-11-26 | 2026-07-21 |
| Patient Controlled Administration of Liquid Acetaminophen Acetaminophen 650 mg Oral Tablet, Acetaminophen 650mg Liquid, CADD pump - Pain, Pain, Postoperative | Phase 1 | Completed | Yale University | 24 | 2024-11-19 | 2026-08-06 |
| CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Diffuse Midline Glioma, H3 K27-Altered, Metastatic Malignant Neoplasm in the Central Nervous System | Phase 1 / Phase 2 | Recruiting | Children's Oncology Group | 63 | 2022-01-28 | 2026-09-11 |
| Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Acute Myeloid Leukemia | Phase 1 | Recruiting | OHSU Knight Cancer Institute | 32 | 2021-01-14 | 2026-07-14 |
| Memory & Conditioning Under Anesthesia Dexmedetomidine, Propofol, Fentanyl - Anesthesia, Pain | Phase 1 | Completed | Keith M Vogt | 92 | 2020-07-30 | 2025-04-18 |
| Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients Ergocalciferol 8000 IU/ML Oral Liquid [DRISDOL], Propylene Glycol - Vitamin D Deficiency, Polytrauma | Phase 1 / Phase 2 | Suspended | New York City Health and Hospitals Corporation | 60 | 2017-07-01 | 2019-04-04 |
| Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women Strath® Kräuterhefe Original (liquid) - Overweight | Phase 1 / Phase 2 | Completed | Bio-Strath AG | 26 | 2017-05-11 | 2024-08-26 |
| Multiple Treatments for Ebola Virus Disease (EVD) Azithromycin, Sunitinib and Erlotinib, Atorvastatin and Irbesartan - Ebola Virus Disease | Phase 1 / Phase 2 | Unknown | Clinical Research Management, Inc. | 150 | 2015-04-01 | 2015-03-05 |
| A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma Bendamustine, Obinutuzumab, Polatuzumab vedotin (Liquid) - Lymphoma | Phase 1 / Phase 2 | Completed | Hoffmann-La Roche | 331 | 2014-10-15 | 2022-11-14 |
| IVIG in Acute Ischemic Stroke: A Pilot Study Privigen, Normal Saline - Ischemic Stroke | Phase 1 | Withdrawn | Inova Health Care Services | 2013-03-01 | 2013-11-11 | |
| Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations Dasatinib as tablets, Dasatinib as liquid, Dasatinib as dispersed tablets - Pharmacokinetic Study in Healthy Participants | Phase 1 | Completed | Bristol-Myers Squibb | 141 | 2011-07-01 | 2013-02-11 |
| Hsv 1 and 2 Gowey Protocol Versus Placebo Versabase gel with sarracenia purpurea 20% liquid extract, placebo (versabase gel only) - Herpes | Phase 1 / Phase 2 | Completed | Naturopaths International | 33 | 2011-01-01 | 2011-11-23 |
| Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus 300 mg LX4211 (150 mg tablets), 300 mg LX4211 (50 mg tablets), 300 mg LX4211 (liquid) - Type 2 Diabetes Mellitus | Phase 1 | Completed | Lexicon Pharmaceuticals | 15 | 2010-09-01 | 2011-03-30 |
| Rapamycin Plus Bevacizumab in Advanced Cancers Rapamycin (liquid), Bevacizumab, Rapamycin (Tablets) - Advanced Cancer, Metastatic Cancer | Phase 1 | Completed | University of Chicago | 28 | 2008-04-01 | 2014-01-17 |
Lymphoma (2) · Overweight (2) · Pain (2) · Agnosia (1) · Diabetes Mellitus, Type 2 (1) · Diffuse Intrinsic Pontine Glioma (1) · Hemorrhagic Fever, Ebola (1) · Herpes Simplex (1) · Ischemic Stroke (1) · Leukemia, Myeloid, Acute (1) · Multiple Trauma (1) · Musculoskeletal Diseases (1) · Neoplasm Metastasis (1) · Obesity (1) · Pain, Postoperative (1)
Amgen (1) · Bio-Strath AG (1) · Bristol-Myers Squibb (1) · Children's Oncology Group (1) · Clinical Research Management, Inc. (1) · Hoffmann-La Roche (1) · Inova Health Care Services (1) · Keith M Vogt (1) · Lexicon Pharmaceuticals (1) · Naturopaths International (1) · New York City Health and Hospitals Corporation (1) · OHSU Knight Cancer Institute (1) · University of Chicago (1) · West Kazakhstan Marat Ospanov Medical University (1) · Yale University (1)
United States (12) · Australia (2) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Kazakhstan (1) · Netherlands (1) · South Korea (1) · Spain (1) · Switzerland (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Beverly C Walters, MD (1) · Christopher Woods, MD, MPH (1) · David L Hoover, MD (1) · David S Ziegler (1) · Elie Traer, MD PhD (1) · Ezra Cohen, MD (1) · Jack Cochran, MD (1) · Jinlei Li, MD, PhD (1) · Joel P. Freiman, MD, MPH (1) · John M Griffiss, MD (1) · Keith M Vogt, MD, PhD (1) · Milan Basta, MD (1)
PMID 22739142, PMID 26768569, PMID 31693429, PMID 32705923, PMID 32770353, PMID 33028076, PMID 34749395, PMID 35086141, PMID 37981564, PMID 38843483, PMID 41180818
2014 (1), R35GM146822 (1), UM1CA228823 (1)